Roche, the Swiss pharmaceuticals company, financially backed and sold large quantities of its prescription slimming medicine to the operator of a chain of private UK diet clinics in spite of suspicions at one stage that the pills were being sold illegally.

The case provides insights into the marketing practices of a pharmaceutical company selling a leading drug in the slimming aid sector.